New eye drops aim to soothe dry eyes in patients with nerve disorders
NCT ID NCT07566975
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing VEVYE eye drops (cyclosporine 0.1%) in 50 adults with dry eye disease who also have a neuro-ophthalmic condition, such as neurotrophic keratitis. Participants use the drops twice daily for 6 months. Researchers will measure changes in corneal staining and symptom scores to see if the drops improve signs and symptoms of dry eye in this specific patient group.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cyclosporine ophthalmic solution 0.1% (VEVYE)
What this could lead to
If successful, this could show that VEVYE is a safe and effective short-term option for managing dry eye in people with neuro-ophthalmic conditions.
What could go wrong
This is a small, early observational study with no control group, so results may not be conclusive. It only looks at short-term effects and may not apply to all dry eye patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRY EYE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Neuro Ophthalmology of TX
RECRUITINGHouston, Texas, 77074, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact Phone: •••-•••-•••• Email: •••••@•••••